— Know what they know.
Not Investment Advice

TECX NASDAQ

Tectonic Therapeutic, Inc.
1W: -2.4% 1M: -5.1% 3M: +29.2% YTD: +30.5% 1Y: +30.0% 3Y: +255.3% 5Y: -74.1%
$28.84
+1.55 (+5.68%)
After Hours: $30.33 (+1.49, +5.17%)
Weekly Expected Move ±8.9%
$23 $25 $28 $30 $33
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 37 · $514.9M mcap · 11M float · 2.37% daily turnover · Short 48% of daily vol
Smart Money Score
Moderate 50
Insider+$0.2M
Congress
ETF Holdings
Key Statistics
Market Cap$514.9M
52W Range14.39-36.03
Volume210,248
Avg Volume266,355
Beta1.21
Dividend
Analyst Ratings
4 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOAlise S. Reicin
Employees51
SectorHealthcare
IndustryBiotechnology
IPO Date2018-06-21
490 Arsenal Way
Watertown, MA 02472
US
+1 617 830 5233
About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Ruddy Marcella K. S-Sale 1,065 $30.00 2026-05-04
Ruddy Marcella K. S-Sale 1,000 $31.05 2026-04-01
Nader Francois A-Award 20,400 $30.78 2026-04-01
Nader Francois 0 2026-04-01
Ruddy Marcella K. S-Sale 10,000 $30.00 2026-03-06

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms